DE69604071D1 - Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung - Google Patents

Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung

Info

Publication number: DE69604071D1
Authority: DE; Germany
Prior art keywords: production; therapeutic use; oxazolidinone derivatives; oxazolidinone; derivatives
Prior art date: 1995-06-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69604071T

Other languages

English (en)

Other versions

DE69604071T2 (de

Inventor

Samir Jegham

Frederic Puech

Philippe Burnier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Synthelabo SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-02

Filing date

1996-05-28

Publication date

1999-10-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69604071(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-02 Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr

1995-06-02 Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr

1996-05-28 Application filed by Synthelabo SA filed Critical Synthelabo SA

1999-10-07 Application granted granted Critical

1999-10-07 Publication of DE69604071D1 publication Critical patent/DE69604071D1/de

2000-04-06 Publication of DE69604071T2 publication Critical patent/DE69604071T2/de

2016-05-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DE69604071T 1995-06-02 1996-05-28 Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung Expired - Lifetime DE69604071T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9506563A FR2734820B1 (fr)	1995-06-02	1995-06-02	Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506564A FR2734821B1 (fr)	1995-06-02	1995-06-02	Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr)	1995-06-02	1996-05-28	Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (2)

Publication Number	Publication Date
DE69604071D1 true DE69604071D1 (de)	1999-10-07
DE69604071T2 DE69604071T2 (de)	2000-04-06

Family

ID=26232004

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69604071T Expired - Lifetime DE69604071T2 (de)	1995-06-02	1996-05-28	Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung

Country Status (27)

Country	Link
US (1)	US5843975A (de)
EP (1)	EP0835254B1 (de)
JP (1)	JP3856829B2 (de)
KR (1)	KR100457502B1 (de)
CN (1)	CN1075072C (de)
AR (1)	AR006301A1 (de)
AT (1)	ATE184005T1 (de)
AU (1)	AU699367B2 (de)
BR (1)	BR9608896A (de)
CA (1)	CA2223011C (de)
CO (1)	CO4700462A1 (de)
CZ (1)	CZ378497A3 (de)
DE (1)	DE69604071T2 (de)
DK (1)	DK0835254T3 (de)
ES (1)	ES2138346T3 (de)
GR (1)	GR3031710T3 (de)
HK (1)	HK1014938A1 (de)
HU (1)	HU224879B1 (de)
MX (1)	MX9709410A (de)
NO (1)	NO309091B1 (de)
NZ (1)	NZ310487A (de)
PL (1)	PL183919B1 (de)
RU (1)	RU2164226C2 (de)
SK (1)	SK281934B6 (de)
TW (1)	TW360654B (de)
WO (1)	WO1996038444A1 (de)
ZA (1)	ZA964563B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1078632A1 (de) *	1999-08-16	2001-02-28	Sanofi-Synthelabo	Verwendung von Monoamin Oxydase Inhibitoren zu Herstellung eines Medikaments zur Behandlung der Fettleibigkeit
EP2140862A3 (de) *	2001-01-31	2010-02-17	H.Lundbeck A/S	Verwendung von GAL3-Rezeptor-Antagonisten zur Behandlung von Depression und/oder Angstzuständen und für solche Verfahren nützliche Verbindungen
CA2460145C (en) *	2001-09-26	2011-04-26	Pharmacia Italia S.P.A.	Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EP2032565A2 (de) *	2006-02-01	2009-03-11	Pfizer Products Inc.	Benzisoxazoloxazolidinone als antibakterielle mittel
JPWO2008120655A1 (ja) *	2007-03-30	2010-07-15	株式会社医薬分子設計研究所	Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) *	2008-05-21	2009-11-25	Bayer CropScience AG	(1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
US8263781B2 (en) *	2009-12-18	2012-09-11	Janssen Pharmaceutica Nv	Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
AU2011218268A1 (en) *	2010-02-17	2012-09-06	Janssen Pharmaceutica Nv	Aminothiazolones as estrogen related receptor-alpha modulators
WO2016097355A1 (en) *	2014-12-19	2016-06-23	Ge Healthcare Limited	Labelled oxazolidinone derivatives
DE102015012050A1 (de) *	2015-09-15	2017-03-16	Merck Patent Gmbh	Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) *	2016-09-05	2017-12-05	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ)	Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2653017B1 (fr) *	1989-10-17	1995-05-05	Delalande Sa	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5196543A (en) *	1989-10-17	1993-03-23	Delalande S.A.	3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) *	1989-10-17	1993-08-10	Delalande S.A.	Process of preparing by condensation certain
US5182296A (en) *	1989-10-26	1993-01-26	Tanabe Seiyaky Co., Ltd.	Naphthyloxazolidone derivatives
FR2671350A1 (fr) *	1991-01-08	1992-07-10	Adir	Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
CA2079906A1 (en) *	1991-02-20	1992-08-21	Yusaku Koda	Articulator

1996
- 1996-05-28 WO PCT/FR1996/000792 patent/WO1996038444A1/fr active IP Right Grant
- 1996-05-28 HU HU9901349A patent/HU224879B1/hu unknown
- 1996-05-28 KR KR1019970708666A patent/KR100457502B1/ko not_active Expired - Lifetime
- 1996-05-28 AT AT96918719T patent/ATE184005T1/de active
- 1996-05-28 DE DE69604071T patent/DE69604071T2/de not_active Expired - Lifetime
- 1996-05-28 SK SK1614-97A patent/SK281934B6/sk not_active IP Right Cessation
- 1996-05-28 DK DK96918719T patent/DK0835254T3/da active
- 1996-05-28 US US08/973,246 patent/US5843975A/en not_active Expired - Lifetime
- 1996-05-28 EP EP96918719A patent/EP0835254B1/de not_active Expired - Lifetime
- 1996-05-28 AU AU61288/96A patent/AU699367B2/en not_active Expired
- 1996-05-28 BR BR9608896A patent/BR9608896A/pt active IP Right Grant
- 1996-05-28 CZ CZ973784A patent/CZ378497A3/cs unknown
- 1996-05-28 JP JP53624596A patent/JP3856829B2/ja not_active Expired - Lifetime
- 1996-05-28 ES ES96918719T patent/ES2138346T3/es not_active Expired - Lifetime
- 1996-05-28 PL PL96323673A patent/PL183919B1/pl unknown
- 1996-05-28 NZ NZ310487A patent/NZ310487A/xx not_active IP Right Cessation
- 1996-05-28 CN CN96195713A patent/CN1075072C/zh not_active Expired - Lifetime
- 1996-05-28 RU RU98100257/04A patent/RU2164226C2/ru active
- 1996-05-28 CA CA002223011A patent/CA2223011C/en not_active Expired - Lifetime
- 1996-05-31 CO CO96028173A patent/CO4700462A1/es unknown
- 1996-06-01 TW TW085106564A patent/TW360654B/zh not_active IP Right Cessation
- 1996-06-03 ZA ZA964563A patent/ZA964563B/xx unknown
- 1996-06-03 AR ARP960102870A patent/AR006301A1/es active IP Right Grant
1997
- 1997-12-01 NO NO975530A patent/NO309091B1/no not_active IP Right Cessation
- 1997-12-02 MX MX9709410A patent/MX9709410A/es unknown
1998
- 1998-12-30 HK HK98119245A patent/HK1014938A1/xx not_active IP Right Cessation
1999
- 1999-11-03 GR GR990402802T patent/GR3031710T3/el unknown

Also Published As

Publication number	Publication date
JP3856829B2 (ja)	2006-12-13
BR9608896A (pt)	1999-06-29
AU699367B2 (en)	1998-12-03
DE69604071T2 (de)	2000-04-06
MX9709410A (es)	1998-07-31
DK0835254T3 (da)	2000-03-27
AU6128896A (en)	1996-12-18
SK281934B6 (sk)	2001-09-11
CN1075072C (zh)	2001-11-21
HUP9901349A3 (en)	2000-02-28
ZA964563B (en)	1996-12-12
HUP9901349A2 (hu)	1999-08-30
CA2223011A1 (en)	1996-12-05
HU224879B1 (en)	2006-03-28
NO975530D0 (no)	1997-12-01
GR3031710T3 (en)	2000-02-29
TW360654B (en)	1999-06-11
PL183919B1 (pl)	2002-08-30
EP0835254A1 (de)	1998-04-15
PL323673A1 (en)	1998-04-14
HK1014938A1 (en)	1999-10-08
EP0835254B1 (de)	1999-09-01
JPH11507330A (ja)	1999-06-29
AR006301A1 (es)	1999-08-25
RU2164226C2 (ru)	2001-03-20
CO4700462A1 (es)	1998-12-29
KR100457502B1 (ko)	2005-09-05
ES2138346T3 (es)	2000-01-01
NO975530L (no)	1998-02-02
WO1996038444A1 (fr)	1996-12-05
CZ378497A3 (cs)	1998-04-15
KR19990022187A (ko)	1999-03-25
CN1191534A (zh)	1998-08-26
NO309091B1 (no)	2000-12-11
SK161497A3 (en)	1998-05-06
NZ310487A (en)	1999-05-28
CA2223011C (en)	2007-01-09
US5843975A (en)	1998-12-01
ATE184005T1 (de)	1999-09-15

Publication	Publication Date	Title
DE69627411D1 (de)	2003-05-22	Triazinderivate, ihre Herstellung und Verwendung
ATE258549T1 (de)	2004-02-15	Oxazolidindion-derivate, ihre herstellung und verwendung
ATE243682T1 (de)	2003-07-15	Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide
DE69623992D1 (de)	2002-10-31	Derivate von dolestatin, deren herstellung und verwendung
DE69806831D1 (de)	2002-09-05	Dithiolan Derivate, deren Herstellung und deren Heileffekt
DE69529026D1 (de)	2003-01-16	Trehalose, ihre Herstellung und ihre Verwendung
DE69821623D1 (de)	2004-03-18	Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
DE59808281D1 (de)	2003-06-12	Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE69625857D1 (de)	2003-02-27	Siliconderivate, ihre Herstellung und Verwendung
DE60001451D1 (de)	2003-03-27	1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
ATE239693T1 (de)	2003-05-15	3,3-diarylpropylamine , ihre verwendung und herstellung
ATE231869T1 (de)	2003-02-15	Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE69901177D1 (de)	2002-05-08	Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69521595D1 (de)	2001-08-09	Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE59409541D1 (de)	2000-11-02	Bicyclen-derivate, ihre herstellung und verwendung
DE69713124D1 (de)	2002-07-11	1H-PYRIDO[3,4-b]INDOLCARBOXAMIDDERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG
DE69604071D1 (de)	1999-10-07	Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE69723463D1 (de)	2003-08-14	Cyclische organoselenderivate, ihre herstellung und verwendung
DE59711704D1 (de)	2004-07-15	Neue carbonsäurederivate, ihre herstellung und verwendung
DE59802922D1 (de)	2002-03-14	3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
DE69330075D1 (de)	2001-05-10	Oxazolinderivate, ihre Herstellung und Anwendung
DE69630391D1 (de)	2003-11-20	Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE59606806D1 (de)	2001-05-23	Polymerholz-formkörper, ihre herstellung und verwendung
DE69514398D1 (de)	2000-02-17	13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung
DE69327813D1 (de)	2000-03-16	Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung

Legal Events

Date	Code	Title	Description
2000-09-21	8364	No opposition during term of opposition
2000-12-28	8327	Change in the person/name/address of the patent owner	Owner name: SANOFI-SYNTHELABO, PARIS, FR
2005-04-21	8327	Change in the person/name/address of the patent owner	Owner name: SANOFI-AVENTIS, PARIS, FR
2013-02-05	R082	Change of representative	Ref document number: 835254 Country of ref document: EP Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE